Drugmaker Perrigo to buy Ireland's Elan for $8.6 billion

DUBLIN (Reuters) – U.S. drugmaker Perrigo agreed to buy Elan for $8.6 billion in a deal that will hand it tax savings from being domiciled in Ireland and royalties from a blockbuster multiple sclerosis treatment.

Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.